Denteric’s GPV381 enters Phase 2, but can a therapeutic vaccine really change periodontitis care?
Denteric’s GPV381 has entered Phase 2 in periodontitis. Read why the gingipain-targeting vaccine could test a new treatment model.
Pharma & Biotech